Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Back

ESC Professional Premium Access

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Session: Prediction and management of cardiovascular risk for patients with cancer

Topic: Cardio-Oncology

Speaker: Doctor D. Leong (Hamilton, CA)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Darryl Leong

Population Health Research Institute, Hamilton (Canada)

7 presentations

0 follower

4 more presentations in this session

State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

Speaker: Doctor A. Lyon (London, GB)

Access

Slides

Video

Risk prediction model of cardiotoxicity in breast cancer patients; the multicenter prospective CHECK HEART-BC (comprehensive heart imaging to evaluate cardiac damage linked with chemotherapy in breast

Speaker: Doctor Y. Terui (Sendai, JP)

Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.

Speaker: Doctor C. Ricaurte Carmona (Rochester, US)

Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era

Speaker: Doctor R. Chatani (Kurashiki, JP)

Access the full session

Prediction and management of cardiovascular risk for patients with cancer

Speakers: Doctor D. Leong, Doctor A. Lyon, Doctor Y. Terui, Doctor C. Ricaurte Carmona, Doctor R. Chatani

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources